Tag: cancer
-
Andarix Pharmaceuticals CEO to Chair Radiopharmaceutical Conference
February 26, 2025 Targeted Radiotherapies: A New Approach to Treating Cancer Boston — ANDARIX Pharmaceuticals, a leader in the discovery and development of targeted peptide therapy for rare cancers, announced today that its CEO, Chris Adams, will chair a session at the targeted therapy conference in Boston. The conference will include attendees from industry experts…
-
Andarix Pharmaceuticals CEO to Groundbreaking Targeted Peptide Therapy at Clinical Trials Conference
October 23, 2024 Innovative Approach to Rare Cancer Treatment Attracts Attention from Industry Leaders and Patient Groups Boston — Andarix Pharmaceuticals, a leader in the discovery and development of targeted peptide therapy for rare cancers, announced today that its CEO, Chris Adams will present the two-day conference on outsourcing clinical trials. The conference will include…